Home/Filings/4/0001373604-25-000067
4//SEC Filing

Leonard Braden Michael 4

Accession 0001373604-25-000067

CIK 0001501756other

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 3:24 PM ET

Size

8.1 KB

Accession

0001373604-25-000067

Insider Transaction Report

Form 4
Period: 2025-03-26
Transactions
  • Purchase

    Common Stock

    2025-03-27$5.19/sh+16,593$86,089141,800 total
  • Purchase

    Common Stock

    2025-03-26$5.04/sh+20,407$102,841125,207 total
Holdings
  • Common Stock

    (indirect: Holding of BML Investment Partners, L.P.)
    2,722,761
Footnotes (4)
  • [F1]Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $5.0395 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares bought at each separate price within the range.
  • [F2]Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $5.1883 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares bought at each separate price within the range
  • [F3]BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
  • [F4]This amendment is being filed to correct BOX 4 on the transaction date of 3/27/25 to correct a clerical error. BOX 4 has been amended to "A", as the shares were acquired, not disposed.

Documents

1 file

Issuer

Adverum Biotechnologies, Inc.

CIK 0001501756

Entity typeother

Related Parties

1
  • filerCIK 0001373603

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 3:24 PM ET
Size
8.1 KB